Clinical Trials for COVID-19
ProSciento is a global CRO with a state-of-the-art clinical research unit (CRU) in Chula Vista, California, conducting clinical trials for COVID-19 vaccines and therapies in healthy subject populations. ProSciento’s CRU includes on-site clinical, subject recruitment (with a database of >30,000 active subjects), and pharmaceutical teams that are widely recognized for their expertise in early phase studies. The facility has 30,000 square feet of treatment and related office space, including 30+ treatment beds, CLIA-certified laboratory, and USP 797/800 standard clean room. The CRU has in-house extended stay capabilities of up to 8 weeks.
Designing and conducting early phase clinical trials
Early phase clinical projects completed
Clinical studies in biologics